NASDAQ: CGCTCartesian Growth Corp III Stock
$10.13+0.00 (+0%)
Updated Nov 13, 2025
CGCT Price
$10.13
Fair Value Price
-$8.33
Market Cap
$349.49M
52 Week Low
$10.00
52 Week High
$10.22
P/E
N/A
P/B
-27.94x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.08
Operating Cash Flow
N/A
Beta
0.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CGCT Overview
Cartesian Growth Corporation III is a blank check company incorporated in 2024 as a Cayman Islands exempted company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CGCT's potential to beat the market
- CGCT doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
CGCT
RankedUnranked of 29
RankedUnranked of 29
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.95 | C | |
| $10.14 | C | |
| $10.02 | C |
Be the first to know about important CGCT news, forecast changes, insider trades & much more!
CGCT News
Overview
Due Diligence Score
–
Industry Average (6)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CGCT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CGCT ($10.13) is overvalued by 221.68% relative to our estimate of its Fair Value price of -$8.33 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CGCT ($10.13) is not significantly undervalued (221.68%) relative to our estimate of its Fair Value price of -$8.33 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CGCT's short-term assets ($960.09k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
There are 30 more CGCT due diligence checks available for Premium users.
Valuation
CGCT fair value
Fair Value of CGCT stock based on Discounted Cash Flow (DCF)
Price
$10.13
Fair Value
-$8.33
Undervalued by
221.68%
CGCT ($10.13) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CGCT ($10.13) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CGCT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-27.94x
Industry
-60.45x
CGCT's financial health
Profit margin
Revenue
$0.0
Net Income
$1.3M
Profit Margin
0%
Assets to liabilities
Assets
$278.8M
Liabilities
$13.6M
Debt to equity
-1.08
CGCT's short-term assets ($960.09k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CGCT's long-term liabilities ($13.14M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CGCT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CGCT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$301.4k
Investing
$0.0
Financing
$0.0
CGCT vs Shell Company Stocks
Cartesian Growth III Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.